Pages that link to "Q6946"
Jump to navigation
Jump to search
The following pages link to Cytomegalovirus (Q6946):
Displayed 50 items.
- human betaherpesvirus 5 (Q6929) (← links)
- Stanley Plotkin (Q7599873) (← links)
- Category:Cytomegalovirus (Q9436415) (← links)
- Aotine herpesvirus 1 (Q18965168) (← links)
- Cebine herpesvirus 1 (Q18965170) (← links)
- Cercopithecine herpesvirus 5 (Q18965171) (← links)
- Macacine herpesvirus 3 (Q18965174) (← links)
- Panine herpesvirus 2 (Q18965176) (← links)
- Papiine herpesvirus 3 (Q18965177) (← links)
- Saimiriine herpesvirus 4 (Q18965178) (← links)
- (Q12456426) (redirect page) (← links)
- Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex (Q21089588) (← links)
- The human cytomegalovirus UL11 protein interacts with the receptor tyrosine phosphatase CD45, resulting in functional paralysis of T cells (Q21090492) (← links)
- Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus (Q21092179) (← links)
- Cytomegalovirus infection causes an increase of arterial blood pressure (Q21131578) (← links)
- Cytomegalovirus-induced immunopathology and its clinical consequences (Q21195897) (← links)
- Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18. (Q21256433) (← links)
- Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host (Q21261782) (← links)
- BST2/Tetherin enhances entry of human cytomegalovirus (Q21559401) (← links)
- Cloning and epitope mapping of a functional partial fusion receptor for human cytomegalovirus gH (Q22011097) (← links)
- Epstein-Barr virus and cytomegalovirus infections cause false-positive results in IgM two-test protocol for early Lyme borreliosis (Q22252809) (← links)
- Functional interaction between pleiotropic transactivator pUL69 of human cytomegalovirus and the human homolog of yeast chromatin regulatory protein SPT6 (Q22254757) (← links)
- Cytomegalovirus induces T-cell independent apoptosis in brain during immunodeficiency (Q23778635) (← links)
- Disordered migration and loss of virus-infected neuronal cells in developing mouse brains infected with murine cytomegalovirus (Q23778642) (← links)
- Immunoglobulin genes influence the magnitude of humoral immunity to cytomegalovirus glycoprotein B (Q23914428) (← links)
- Prevalence of Cytomegalovirus Antibody in Nursing Personnel (Q24091390) (← links)
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients (Q24200697) (← links)
- Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients (Q24200991) (← links)
- Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant (Q24235578) (← links)
- Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant (Q24240129) (← links)
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients (Q24243124) (← links)
- Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients (Q24244606) (← links)
- Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients (Q24245120) (← links)
- Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients (Q24245346) (← links)
- Antiviral medication for preventing cytomegalovirus disease in solid organ transplant recipients (Q24245543) (← links)
- Immunoglobulins and vaccines for preventing cytomegalovirus disease in solid organ transplant recipients (Q24245575) (← links)
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients (Q24245848) (← links)
- Antiviral therapy for symptomatic congenital cytomegalovirus infection in neonates and infants up to 3 months of age (Q24248089) (← links)
- Congenital cytomegalovirus infection: patterns of fetal brain damage (Q24276226) (← links)
- Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus (Q24292060) (← links)
- Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication (Q24293059) (← links)
- The granzyme B inhibitor SERPINB9 (protease inhibitor 9) circulates in blood and increases on primary cytomegalovirus infection after renal transplantation (Q24293561) (← links)
- Structural elements underlying the high binding affinity of human cytomegalovirus UL18 to leukocyte immunoglobulin-like receptor-1 (Q24293670) (← links)
- Bicaudal D1-dependent trafficking of human cytomegalovirus tegument protein pp150 in virus-infected cells (Q24296677) (← links)
- Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections (Q24298226) (← links)
- Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity (Q24300637) (← links)
- The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism (Q24300688) (← links)
- Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity (Q24303742) (← links)
- The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication (Q24304029) (← links)
- Repression of HMGA2 gene expression by human cytomegalovirus involves the IE2 86-kilodalton protein and is necessary for efficient viral replication and inhibition of cyclin A transcription (Q24304994) (← links)